GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Marksans Pharma Ltd

Marksans Pharma: Aug 20 record date for ₹0.90 final dividend for FY26

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Jul 2026, 12:34 PM IST  ·  BSE ID: c02af4a1-9471-476c-be0b-8940605b6372
View Original BSE Filing (PDF)
💡
In Simple Terms
Marksans Pharma will pay a ₹0.90 per share final dividend for FY2026, with August 20, 2026, as the date to check eligibility.
🤖 AI Summary
  • August 20, 2026, set as record date for ₹0.90 per share final dividend for FY2026.
  • 34th Annual General Meeting scheduled for August 27, 2026, via Video Conference.
  • Final dividend payment, if approved, is expected on or after September 10, 2026.
  • Board meeting on July 03, 2026, considered and approved AGM and dividend-related matters.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹0.90
Record Date
20 August 2026
AGM Date
27 August 2026
Dividend Payment Date
on or after 10 September 2026
🏢 How This Affects the Company
💰
Financial Impact
Confirms final dividend payout, subject to shareholder approval, impacting cash outflow upon payment.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should ensure their holdings are in order by the record date.
👤
Who Is Affected
All shareholders of record as of August 20, 2026, are eligible to receive the final dividend, subject to AGM approval.
🔍
Management Signal
Management is proceeding with the distribution of profits to shareholders as recommended.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM notice and Annual Report publication for FY2026.
Shareholder approval of the final dividend at the AGM.
Actual dividend payment on or after September 10, 2026.
LOW RISK Dividend declaration is a routine corporate action with minimal new risks introduced.
💡 Investor Takeaway
Marksans Pharma set August 20, 2026, as the record date for a final dividend of ₹0.90 per equity share for FY2026.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmation of ₹0.90 per share final dividend for FY2026 provides clarity for shareholders.
  • AGM scheduled for August 27, 2026, allows for formal approval of dividend and annual reports.
📅 Company Track Record
Marksans Pharma had previously recommended a final dividend of ₹0.90 per share for FY2025-26 on May 26, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the record date for Marksans Pharma's final dividend for FY2026?
The record date for Marksans Pharma's final dividend for the financial year ended March 31, 2026, is August 20, 2026.
What is the amount of the final dividend per share for Marksans Pharma for FY2026?
Marksans Pharma has recommended a final dividend of ₹0.90 per equity share, subject to member approval at the AGM.
When will the final dividend be paid by Marksans Pharma if approved?
The final dividend, if approved at the AGM, will be paid on or after September 10, 2026.
When is the 34th Annual General Meeting of Marksans Pharma?
The 34th Annual General Meeting of Marksans Pharma will be held on Thursday, August 27, 2026, at 11:00 a.m. IST.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.